Compositions and methods for stabilizing liposomal camptothecin formulations

Details for Australian Patent Application No. 2005304914 (hide)

Owner Tekmira Pharmaceuticals Corporation

Inventors Hope, Michael J.; Mui, Barbara; Madden, Thomas D.

Agent Spruson & Ferguson

Pub. Number AU-B-2005304914

PCT Pub. Number WO2006/052767

Priority 60/625,199 05.11.04 US

Filing date 4 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 16 February 2012

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/47 (2006.01) - Quinolines

A61K 31/4745 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052767 Priority application(s): WO2006/052767

16 February 2012 Assignment before Grant

  Inex Pharmaceuticals Corporation The application has been assigned to Tekmira Pharmaceuticals Corporation 2006

16 February 2012 Application Accepted

  Published as AU-B-2005304914

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304915-Process for preparing quinoline compounds and products obtained therefrom

2005304912-Cycle and load measurement device